TOPIRAMATE

Generic: TOPIRAMATE

Aurobindo Pharma LimitedManufacturer
ORALRoute
TOPIRAMATEActive Substance
2023-09-27Original Approval

TOPIRAMATE is FDA application ANDA215449, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
7,043 reports
2
OFF LABEL USE
5,695 reports
3
HEADACHE
3,683 reports
4
NAUSEA
3,328 reports
5
FATIGUE
3,197 reports
6
PRODUCT USE IN UNAPPROVED INDICATION
2,623 reports
7
PAIN
2,574 reports
8
MIGRAINE
2,545 reports
9
DIZZINESS
2,421 reports
10
SEIZURE
2,273 reports